Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2006 1
2010 2
2011 1
2019 1
2020 1
2022 1
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for schartman j[au]
Your search for Scharfman J[au] retrieved no results
Adverse events after intravitreal infliximab (Remicade).
Giganti M, Beer PM, Lemanski N, Hartman C, Schartman J, Falk N. Giganti M, et al. Among authors: schartman j. Retina. 2010 Jan;30(1):71-80. doi: 10.1097/IAE.0b013e3181bcef3b. Retina. 2010. PMID: 19996827 Clinical Trial.
One-Year and 18-Month Outcomes in nAMD Patient Eyes Switched to Brolucizumab Alone versus to Brolucizumab Alternating with Other Anti-VEGF Agents.
Coney JM, McCoy JE, Buxy Sinha S, Sonbolian N, Zhou L, Hull TP, Lewis SA, Miller DG, Novak MA, Pendergast SD, Pham H, Platt SM, Rao LJ, Schartman JP, Singerman LJ, Donkor R, Fink M, Zubricky R, Karcher H. Coney JM, et al. Among authors: schartman jp. Clin Ophthalmol. 2023 Nov 23;17:3601-3611. doi: 10.2147/OPTH.S432957. eCollection 2023. Clin Ophthalmol. 2023. PMID: 38026599 Free PMC article.
Switching to brolucizumab: injection intervals and visual, anatomical and safety outcomes at 12 and 18 months in real-world eyes with neovascular age-related macular degeneration.
Coney JM, Zubricky R, Sinha SB, Sonbolian N, Zhou L, Hull TP, Lewis SA, Miller DG, Novak MA, Pendergast SD, Pham H, Platt SM, Rao LJ, Schartman JP, Singerman LJ, Donkor R, Fink M, McCoy J, Karcher H. Coney JM, et al. Among authors: schartman jp. Int J Retina Vitreous. 2023 Feb 1;9(1):8. doi: 10.1186/s40942-023-00445-0. Int J Retina Vitreous. 2023. PMID: 36726178 Free PMC article.